Search term: consultation
2008 / 05
Your search is limited to one month, search the whole site for consultation.
PHARMAC documents that matched your search:
As you are aware, PHARMAC is reviewing the ‘Guidelines for the Pharmacology and Therapeutics Advisory Committee (PTAC) and its Sub-Committees’ which detail the terms of reference for these PHARMAC advisory committees...
Proposal summary PHARMAC and Rex Medical Ltd have reached a provisional agreement for funding of a new treatment for epilepsy, levetiracetam. Under this agreement, Rex Medical’s brand of levetiracetam (Levetiracetam-Rex) would be funded without…
Proposal for sole supply arrangement for citalopram hydrobromide
(3 pages, 126 KB)
Proposal summary PHARMAC and Arrow Pharmaceuticals (NZ) Ltd have reached a provisional agreement for the supply of Arrow-Citalopram, one of the three brands of citalopram hydrobromide currently funded by…
Proposal to amend the listings of venom allergy kits
(2 pages, 114 KB)
Following feedback from clinicians, PHARMAC is proposing to change the listing description of bee and wasp venom allergy kits in the Pharmaceutical Schedule. Please note that this proposal…
Proposal summary PHARMAC and Bristol-Myers Squibb have reached a provisional agreement for funding of a new treatment for schizophrenia, aripiprazole (Abilify), from 1 August 2008. Aripiprazole (Abilify) would be fully subsidised for…
Proposal summary PHARMAC currently subsidises the antipsychotic treatment clozapine in a tablet formulation. Two brands are subsidised: Clozaril (25 mg and 100…
Review of PTAC's Guidelines background information
(9 pages, 151 KB)
Review of the Guidelines for the Pharmacology and Therapeutics Advisory Committee (PTAC) and its Subcommittees Introduction PTAC is a statutory committee established “to provide objective advice to PHARMAC on pharmaceuticals and their benefits”.
PHARMAC is reviewing PTAC’s Guidelines and I would like to invite you to consider the proposed amendments that PHARMAC is putting forward. I welcome your views on those proposals and any further changes to the Guidelines that you consider would be desirable.
Extension to consultation on fentanyl patch proposal
(1 page, 159 KB)
6 May 2008 CONSULTATION ON PROPOSAL TO WIDEN ACCESS TO FENTANYL PATCHES – EXTENSION TO RESPONSE DEADLINE PHARMAC has received requests to extend the deadline for responses to consultation on a proposal to widen access to fentanyl transdermal patches (consultation…